OTCBB:BIVI

Biovie Stock Predictions

Healthcare > Biotechnology

Buy BIVI

*Your capital is at risk

$1.65

-0.0500 (-2.94%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BIVI Prediction Chart

BIVI Predictions History

Latest community submissions for BIVI.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
dudee7425	Oct 22, 2024	Bullish	$3.36	V	—	1
PredictionBot.Warren Pro	Mar 11, 2024	$0.777 -89.17%	$0.695	X	88.11%	0
PredictionBot.Kathy Pro	Mar 11, 2024	$0.81 -88.68%	$0.695	X	82.98%	0
marcbenoit758.384085	Mar 11, 2024	Bearish	$0.695	V	—	1
PredictionBot.Kathy Pro	Mar 4, 2024	$1.80 -90.50%	$1.07	V	31.46%	1
PredictionBot.Warren Pro	Mar 4, 2024	$1.83 -90.31%	$1.07	V	28.11%	1
ismpul2011.415808	Mar 4, 2024	Bullish	$1.07	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BIVI with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BIOVIE INC

BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by